#LetsTakeDown6cSellWall, page-7

I love all the optimism good luck to all

who thinks they have an idea of when and how this will get rerated by the market?

no doubt a series of potential catalysts get closer by the day both on a micro level with in zelira and at the macro with exponentially growing legal prescribees in oz, over the counter cbd changes that should trigger some new capital interest, subsidies via PBS and then maybe even some news on the US front around federal legalisation...

patience .... difficult ... but plenty to suggest a major wave of interest will come back into the space at some point.

this does however look more and more like the dot.com bubble ... internet was always going to be massive and host a new market of giants emerging to meet that need ... took a while though... years for the industry to catch up.

we all know the cannibas cats been let out the bag and meeting that need is massive, both on a traditional pharma level treating established, existing indications ... and then ofcourse all the general gaps cannibas lovers will find to get prescribed with ...


worst case scenario is it takes a few years for the industry to catch up with streamlined access and a robust market of prescribees, prescribers and stocked dispeneries/chemists.

best case scenario is zelira aligns its development with this and does what is sais it will do ...

finalising a tangible portfolio of proprietary new drugs that are clinically validated as effective in treating established medical needs, released alongside existing therapies and stealing market share with every quarter.